Multiple Sclerosis Trial, Recruiting (NCT07571304)

Multiple Sclerosis Trial, Recruiting NCT07571304 Sponsor: Istanbul University - Cerrahpasa Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT07571304 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

"Who might be able to join this trial:

People who have been diagnosed with multiple sclerosis that started in childhood or adolescence, confirmed using specific medical guidelines called the 2017 revised McDonald criteria
People who are between 12 and 18 years old
People whose level of physical disability, as measured by a standard scale called the EDSS, falls below a score of 6 (meaning they can still walk, at least with some assistance)

Who may not be able to join:

People who have a bone or joint problem (such as a condition affecting the legs, hips, or spine) that affects their ability to move around
People who have significant blurred vision that affects how well they can see
People who have another neurological condition or serious illness in addition to their multiple sclerosis
People who have had a relapse (a flare-up of symptoms) or have received corticosteroid treatment (a type of anti-inflammatory medication) within the past 3 months

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905326006294

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07571304

Sponsor: Istanbul University - Cerrahpasa

Phase: Not Applicable

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: +905326006294

More information: https://clinicaltrials.gov/study/NCT07571304

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

"Who might be able to join this trial:

People who have been diagnosed with multiple sclerosis that started in childhood or adolescence, confirmed using specific medical guidelines called the 2017 revised McDonald criteria
People who are between 12 and 18 years old
People whose level of physical disability, as measured by a standard scale called the EDSS, falls below a score of 6 (meaning they can still walk, at least with some assistance)

Who may not be able to join:

People who have a bone or joint problem (such as a condition affecting the legs, hips, or spine) that affects their ability to move around
People who have significant blurred vision that affects how well they can see
People who have another neurological condition or serious illness in addition to their multiple sclerosis
People who have had a relapse (a flare-up of symptoms) or have received corticosteroid treatment (a type of anti-inflammatory medication) within the past 3 months

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Istanbul University - Cerrahpasa

Registry

ClinicalTrials.gov

Start date

1 April 2026

Est. completion

1 December 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery; 6-Minute Walk Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov